FDA product code JBJ: Glucose-6-Phosphate Dehydrogenase (Erythrocytic), Methemoglobin Reduction
JBJ is the FDA product code for glucose-6-phosphate dehydrogenase (erythrocytic), methemoglobin reduction. It is a Class II device, regulated under 21 CFR 864.7360 and reviewed by the Hematology panel. Devices under JBJ reach the market by 510(k); FDA lists no cleared 510(k)s for it.
Classification
| Field | Value |
|---|---|
| Device name | Glucose-6-Phosphate Dehydrogenase (Erythrocytic), Methemoglobin Reduction |
| Device class | Class II |
| Regulation | 21 CFR 864.7360 |
| Review panel | HE — Hematology |
| Medical specialty | Hematology |
| Premarket route | 510(k) |
| Third-party 510(k) review eligible | Yes |
Recalls for JBJ devices
FDA recall records list no recalls for product code JBJ.
Frequently asked questions
What is FDA product code JBJ?
JBJ is the FDA product code for glucose-6-phosphate dehydrogenase (erythrocytic), methemoglobin reduction. It is a Class II device, regulated under 21 CFR 864.7360 and reviewed by the Hematology panel.
What device class is JBJ?
Class II, regulation 21 CFR 864.7360. Typical premarket route: 510(k).
Next steps
- Run an FDA pathway report with predicate devices for product code JBJ
- Run a recall and safety report across every JBJ manufacturer
- Watch product code JBJ for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Hematology product codes · FDA product code lookup · 510(k) database search · 510(k) review times